|
National Stock Number(NSN): 6505-01-234-4965 (6505012344965, 012344965)
| NIIN: |
01-234-4965 |
Item Name: |
THEOPHYLLINE AND GUAIFENESIN CAPSULES |
INC: |
27085
|
| FSC: |
6505
|
Assignment Date: |
|
CRIT: |
|
IIG: |
27085 |
| ISC: |
5 |
Date Standardized: |
|
HMIC: |
|
DODIC: |
|
| NSC: |
8 |
Cancellation Date: |
May-30-1997 |
PMIC: |
|
FIIG: |
A45000 |
| ESD: |
|
Schedule B: |
|
DEMIL: |
E |
DEMIL INT: |
|
| TIIC: |
1 |
Originator: |
|
ADPEC: |
|
RPDMRC: |
|
| Part Number |
CAGE |
Company |
Status |
RN CC |
RN VC |
DAC |
RN AAC |
RN FC |
RN SC |
RN JC |
SADC |
HCC |
MSDS |
|
0 B CAPSULES |
63998
|
BAXTER HEALTHCARE CORP PHARMACEUTICALS DIV |
H |
5 |
1 |
|
|
|
|
|
|
|
|
|
4635 |
63998
|
BAXTER HEALTHCARE CORP PHARMACEUTICALS DIV |
H |
3 |
2 |
|
|
|
|
|
|
|
|
|
NDC47679-0199-01 |
63998
|
BAXTER HEALTHCARE CORP PHARMACEUTICALS DIV |
H |
3 |
2 |
|
|
|
|
|
|
|
|
Technical Characteristics Information
| MRC |
Requirement Statement |
Reply Statement |
| AKJA |
ACTIVE MEDICAMENT MEDICINAL STRENGTH |
150.000 MILLIGRAMS THEOPHYLLINE,ANHYDROUS ACTIVE INGREDIENT AND 90 MG. GUIFENESIN ACTIVE INGREDIENT MILLIGRAMS THEOPHYLLINE,ANHYDROUS ACTIVE INGREDIENT |
| AKJC |
CAPSULE TYPE |
ANY ACCEPTABLE |
| CQCT |
PRIMARY CONTAINER TYPE |
BOTTLE |
| CQLS |
CAPSULE CONTENT FORM |
GRANULE |
| CRLK |
PRIMARY CONTAINER CONTENT QUANTITY |
250.000 CAPSULES |
| THPE |
THERAPEUTIC EQUIVALENT |
NOT RATED |
|